In November, the real effective interest rate of the Russian ruble decreased by 1.6% from the previous month.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Russian Ministry of Defence: Russian armed forces occupied seven settlements in one week.
Liu Jianchao met with Egyptian Foreign Minister Abdul Ati. On December 13th, Liu Jianchao, Minister of the International Liaison Department of the CPC Central Committee, met with Egyptian Foreign Minister Abdul Ati in Beijing. The two sides exchanged views on implementing the important consensus of the two heads of state, strengthening inter-party exchanges, strengthening political dialogue and humanities exchanges, and promoting the construction of a community of destiny between China and Egypt facing the new era. (Xinhua News Agency)Market News: Director of South Korea's National Police Agency will be arrested.The EUR/USD of the euro against the US dollar rose by 0.50% in the day and is now reported at 1.0518.
Market News: US Secretary of State Blinken met with Iraqi Prime Minister in Baghdad to discuss the Syrian issue.Bei Ya raised Broadcom's target price from $195.00 to $210.00.In November, the real effective interest rate of the Russian ruble decreased by 1.6% from the previous month.
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide